###begin article-title 0
###xml 32 51 32 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Helicobacter pylori</italic>
###xml 32 51 <span type="species:ncbi:210">Helicobacter pylori</span>
Significant association between Helicobacter pylori infection and serum C-reactive protein
###end article-title 0
###begin p 1
Conflict of Interest: The authors have declared that no conflict of interest exists.
###end p 1
###begin p 2
###xml 0 12 0 12 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Background: </bold>
###xml 12 31 12 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Helicobacter pylori</italic>
###xml 33 42 33 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori</italic>
###xml 12 31 <span type="species:ncbi:210">Helicobacter pylori</span>
###xml 33 42 <span type="species:ncbi:210">H. pylori</span>
Background: Helicobacter pylori (H. pylori) infection in gastric mucosa may cause systemic inflammatory reaction. This study aimed to examine the association between the infection and serum high sensitivity C-reactive protein (hsCRP).
###end p 2
###begin p 3
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Methods: </bold>
###xml 467 476 467 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori</italic>
###xml 240 248 <span type="species:ncbi:9606">patients</span>
###xml 316 328 <span type="species:ncbi:9606">participants</span>
###xml 467 476 <span type="species:ncbi:210">H. pylori</span>
Methods: Subjects were comprised of three groups; 453 health checkup examinees from Yakumo town inhabitants in Hokkaido, Japan (YTI, 153 males and 300 females), 449 health checkup examinees (ENUH, 273 males and 176 females), and 255 female patients of an infertility clinic (PIC), Nagoya University Hospital. Twenty participants with hsCRP more than 1 mg/dl were excluded from the analysis. Those with hsCRP more than 0.1mg/dl were defined as high hsCRP individuals. H. pylori infection status was examined with a serum IgG antibody test.
###end p 3
###begin p 4
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Results: </bold>
###xml 207 208 207 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
Results: When the three groups were combined, the geometric mean of hsCRP concentration was significantly higher among the seropositives (0.047mg/dl) than among the seronegatives (0.035mg/dl); p<0.0001 by a t-test. The percentage of high hsCRP individuals was also higher in the seropositives than in the seronegatives among any group; 23.3% and 20.1% in YTI, 22.0% and 16.0% in ENUH, and 32.7% and 18.7% in PIC, respectively, although the difference was significant only in ENUH. The summary odds ratio of the high hsCRP for the seropositives relative to the seronegatives was 1.38 (95% confidence interval, 1.01-1.89), when age, sex, body mass index, smoking, and subject group were adjusted by a logistic model.
###end p 4
###begin p 5
###xml 0 11 0 11 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conclusions</bold>
###xml 116 126 116 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori </italic>
###xml 116 125 <span type="species:ncbi:210">H. pylori</span>
Conclusions: In three groups, hsCRP was higher among the infected individuals. The summary odd ratio indicated that H. pylori infection could influence the serum hsCRP level.
###end p 5
###begin title 6
1. Introduction
###end title 6
###begin p 7
###xml 0 20 0 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Helicobacter pylori </italic>
###xml 21 30 21 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori</italic>
###xml 209 210 209 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 355 356 355 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 423 424 423 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 0 19 <span type="species:ncbi:210">Helicobacter pylori</span>
###xml 21 30 <span type="species:ncbi:210">H. pylori</span>
###xml 168 173 <span type="species:ncbi:9606">child</span>
Helicobacter pylori (H. pylori) is a spiral-shaped, gram-negative bacterium that inhabits the stomach mucosa in more than 50% of Japanese adults, and further more from child to elderly in developing countries 1. This bacterium can elicit lifelong inflammatory and immune responses with release of various bacterial and host-dependent cytotoxic substances 2, resulting in chronic gastritis, peptic ulcer, and gastric cancer 3.
###end p 7
###begin p 8
###xml 44 53 44 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori</italic>
###xml 128 129 128 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 130 131 130 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 153 162 153 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori</italic>
###xml 285 294 285 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori</italic>
###xml 523 524 523 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 526 527 526 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 617 618 617 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 44 53 <span type="species:ncbi:210">H. pylori</span>
###xml 153 162 <span type="species:ncbi:210">H. pylori</span>
###xml 285 294 <span type="species:ncbi:210">H. pylori</span>
Epidemiological studies have suggested that H. pylori infection might be involved in the pathogenesis of coronary heart disease 4-6. The suspicion about H. pylori involvement in the pathological lesions is based on the following: (i) local inflammation can have systemic effects; (ii) H. pylori gastric infection is a chronic process that lasts for decades; and (iii) persistent infection induces chronic inflammatory and immune responses that can induce lesions both local and remote sites from the primary infection site 7, 8. The manifestation may be caused by potential mechanisms with direct or indirect actions 9. The direct effects on the vascular wall could include endothelial injury and dysfunction through circulating endotoxins, smooth muscle proliferation, and local inflammation. The indirect effects are more often pronounced, including elevation of inflammatory mediators with proinflammatory, procoagulant, and atherogenic action, production of cross-reactive antibodies, as well as nutrient/vitamin malabsorption and metabolic disturbances such as overproduction of ammonia by the bacterium.
###end p 8
###begin p 9
###xml 225 227 225 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 431 433 431 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 434 436 434 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 513 515 513 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 569 571 569 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 663 665 663 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
C-reactive protein (CRP) is an acute-phase reactant that originates from the liver. CRP has many clinical and biological effects and can be used for the diagnosis and follow-up of various inflammatory and traumatic processes 10. There is strong evidence that CRP is a powerful predictor of incident cardiovascular events independent of levels of LDL cholesterol, all levels of the Framingham risk score, and the metabolic syndrome 11-19. The basal CRP level in individuals free from acute illness is reproducible 20. Its determinants reportedly include age and smoking 21, while substantial heritability (35-40%) was also reported in familial aggregation studies 22.
###end p 9
###begin p 10
###xml 34 43 34 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori</italic>
###xml 122 132 122 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori </italic>
###xml 279 281 279 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 283 285 283 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 34 43 <span type="species:ncbi:210">H. pylori</span>
###xml 122 131 <span type="species:ncbi:210">H. pylori</span>
Examining the association between H. pylori infection and serum CRP levels seemed important to elucidate the relevance of H. pylori infection with coronary heart disease, especially atherosclerosis. The previous studies on the association, however, provided inconsistent results 23, 24. This study aimed to examine the association in three different Japanese groups.
###end p 10
###begin title 11
2. Subjects and methods
###end title 11
###begin title 12
Study subjects
###end title 12
###begin p 13
The first group (YTI) was 524 apparently healthy inhabitants, who attended a health check-up at Yakumo town, Hokkaido, Japan in 2006. Among them, 505 agreed to participate in the study with written informed consent. Lifestyle data collected with a self-administered questionnaire, as well as residual blood samples, were available from 459 subjects. Six subjects with serum high-sensitivity CRP (hsCRP) > 1 mg/dl were excluded from the analysis, because they might have an inflammatory disease. Remaining 453 subjects (153 males and 300 females) aged from 39 to 90 years were used for the present study.
###end p 13
###begin p 14
###xml 389 399 389 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori </italic>
###xml 389 398 <span type="species:ncbi:210">H. pylori</span>
The second group (ENUH) incorporated health checkup examinees at Department of Clinical Preventive Medicine, Nagoya University Hospital, who visited the department between June 2003 and February 2004. After the explanation of the study, 476 agreed lifestyle questionnaire and donation of 7ml peripheral blood for research purposes. Among them, 453 subjects could determine the presence of H. pylori infection and measure the hsCRP. Those with hsCRP more than 1 mg/dl were also excluded, remaining 449 subjects (273 males and 176 females) aged from 17 to 89 years for the present study.
###end p 14
###begin p 15
###xml 46 54 <span type="species:ncbi:9606">patients</span>
###xml 310 318 <span type="species:ncbi:9606">patients</span>
The third group (PIC) consisted of 264 female patients at an infertility clinic, who underwent treatment for infertility at Department of Obstetrics and Gynecology or Department of Maternal and Perinatal Medicine, Nagoya University Hospital between February 2001 and December 2004. Stored blood samples of the patients were available for research purposes. Those with hsCRP more than 1 mg/dl were similarly excluded, remaining 255 females aged from 21 to 48 years. All the three studies were approved by the Ethics Committee of Nagoya University School of Medicine (approval number 398, 52, 278 for YTI, ENUH and PIC, respectively).
###end p 15
###begin title 16
###xml 23 32 <span type="species:ncbi:210">H. pylori</span>
Determination of serum H. pylori infection and hsCRP value
###end title 16
###begin p 17
###xml 196 206 188 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori </italic>
###xml 287 297 279 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori </italic>
###xml 340 350 332 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori </italic>
###xml 662 672 654 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori </italic>
###xml 196 205 <span type="species:ncbi:210">H. pylori</span>
###xml 287 296 <span type="species:ncbi:210">H. pylori</span>
###xml 340 349 <span type="species:ncbi:210">H. pylori</span>
###xml 662 671 <span type="species:ncbi:210">H. pylori</span>
Sera were separated from blood samples immediately after blood draw. They were kept in a deep freezer at -80 masculineC until analyses. A commercially available direct ELISA kit ("E Plate 'Eiken' H. pylori Antibody" from Eiken Kagaku, Tokyo, Japan) was used to determine the presence of H. pylori infection. The seropositive was defined as H. pylori IgG antibody more than 10 U/ml. The hsCRP was measured with a particle-enhanced immunoturbidometric latex agglutination assay by SRL Co. Ltd., Tokyo. The assay could detect 0.004 mg/dl of CRP. Undetectable CRP values were recorded as 0.002 mg/dl. The staff in the laboratory was blinded to the seropositivity of H. pylori antibody.
###end p 17
###begin title 18
Statistical analysis
###end title 18
###begin p 19
###xml 56 65 56 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori</italic>
###xml 138 139 138 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 157 158 157 158 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e</sub>
###xml 742 743 738 739 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 56 65 <span type="species:ncbi:210">H. pylori</span>
###xml 218 230 <span type="species:ncbi:9606">Participants</span>
The difference in geometric mean of serum hsCRP between H. pylori positive subjects and negative subjects was statistically tested with a t-test, because loge-transformed hsCRP distributed symmetrically with one peak. Participants with hsCRP more than 0.1 mg/dl were defined as high hsCRP individuals in this study. The proportion of high hsCRP subjects was compared between the seropositives and the seronegatives with a Fisher's exact test. Odds ratios (ORs) and 95% confidence intervals (CIs) of the seropositives compared with the seronegatives for high hsCRP were calculated using unconditional logistic regression models, adjusting for age (<30, 30-39, 40-49, 50-59, 60-69, or >==70 years), sex, body mass index (BMI) (<25, or >==25kg/m2), smoking (never, former, current, or unknown), and study group. The heterogeneity in the OR among study groups was tested with the Q statistic. The data were analyzed by the statistical software "STATA/SE version 9.0" (College Station, TX, USA).
###end p 19
###begin title 20
3. Results
###end title 20
###begin p 21
###xml 124 125 124 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
###xml 599 609 599 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori </italic>
###xml 58 70 <span type="species:ncbi:9606">participants</span>
###xml 181 193 <span type="species:ncbi:9606">participants</span>
###xml 386 394 <span type="species:ncbi:9606">patients</span>
###xml 599 608 <span type="species:ncbi:210">H. pylori</span>
The sex, age, hsCRP level, BMI, and smoking habits of the participants according to the study group are summarized in Table 1. In YTI, females were dominant (66.2%), and 65.3% were participants aged 60 years or older. In ENUH, males were dominant (60.8%), and age was distributed over a wider range. PIC was the group of only females aged under 50 years, because they were sampled from patients of an infertility clinic. The hsCRP distributed from undetectable level close to 1 mg/dl in any group, and the frequency of high hsCRP individuals was comparable among the three groups. The prevalence of H. pylori infection in YTI was 62.1% (95/153) in males and 54.7% (164/300) in females, 39.9% (109/273) and 36.9% (65/176) in ENUH, respectively, and 20.4% (52/255) in PIC. In total, the prevalence was 47.9% (204/426) in males and 38.4% (281/731) in females.
###end p 21
###begin p 22
###xml 6 7 6 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
###xml 428 438 426 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori </italic>
###xml 476 486 474 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori </italic>
###xml 810 820 808 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori </italic>
###xml 856 867 854 865 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> H. pylori </italic>
###xml 1025 1035 1023 1033 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori </italic>
###xml 1090 1092 1088 1090 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t-</italic>
###xml 125 137 <span type="species:ncbi:9606">participants</span>
###xml 428 437 <span type="species:ncbi:210">H. pylori</span>
###xml 476 485 <span type="species:ncbi:210">H. pylori</span>
###xml 810 819 <span type="species:ncbi:210">H. pylori</span>
###xml 857 866 <span type="species:ncbi:210">H. pylori</span>
###xml 1025 1034 <span type="species:ncbi:210">H. pylori</span>
Table 2 shows associations of categorized hsCRP (<==0.1 mg/dl or >0.1 mg/dl) with background factors. In YTI, ENUH and whole participants, no significant difference was found in the prevalence of hsCRP between sexes, although the high hsCRP was more prevalent in males of YTI and in females of ENUH. There was no significant difference in the hsCRP level across age groups. The geometric mean of hsCRP level was 0.051 mg/dl for H. pylori positive subjects and 0.042 mg/dl for H. pylori negative subjects in YTI, 0.043 mg/dl and 0.036 mg/dl in ENUH, 0.045 mg/dl and 0.028 mg/dl in PIC, respectively. Corresponding 1st-3rd quartile was 0.025-0.094 and 0.020-0.082 in YTI, 0.023-0.072 and 0.018-0.071 in ENUH, and 0.016-0.143 and 0.010-0.061 in PIC. In total, the geometric mean of hsCRP level was 0.047mg/dl for H. pylori positive subjects and 0.035mg/dl for H. pylori negative subjects, with the 1st-3rd quartile of 0.023-0.093 and 0.015-0.073, respectively. The hsCRP geometric mean was significantly higher in subjects with H. pylori positive subjects than in those without (p<0.0001 by a t-test).
###end p 22
###begin p 23
###xml 78 88 78 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori </italic>
###xml 204 205 204 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">3</xref>
###xml 432 442 432 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori </italic>
###xml 78 87 <span type="species:ncbi:210">H. pylori</span>
###xml 432 441 <span type="species:ncbi:210">H. pylori</span>
In PIC, the high hsCRP level was observed more frequently among subjects with H. pylori infection than among those without it, with a statistically significant difference; 32.7% vs. 18.7%, p=0.037 (Table 3). A similar difference in the prevalence of high hsCRP level was also detected in the pooled population (23.5% vs. 17.7%, p=0.017). In YTI and ENUH groups, the proportion of high hsCRP level was similarly higher in those with H. pylori infection compared with those without it, but the difference was not significant; p=0.491 for YTI and p=0.127 for ENUH.
###end p 23
###begin p 24
###xml 6 7 6 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">3</xref>
###xml 36 46 36 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori </italic>
###xml 36 45 <span type="species:ncbi:210">H. pylori</span>
Table 3 also shows OR and 95% CI of H. pylori seropositivity for the high hsCRP. The ORs were 1.18 (95% CI, 0.74-1.90) in TYI, 1.37 (95% CI, 0.81-2.31) in ENUH, and 2.20 (95% CI, 1.11-4.37) in PIC, after adjustment for age, sex, BMI, and smoking habits. The Q test for heterogeneity showed the differences in the OR among the three groups was not significant (p=0.337). The summary OR was 1.38 (95% CI, 1.01-1.89), with allowance for study groups; 1.20 (95% CI, 0.73-1.95) in males and 1.61 (95% CI, 1.09-1.38) in females. Because the median of the age in pooled data was 52, we divided the data into two groups at the age; the younger group (age<==52 years) and the older group (age>52 years). The summary OR of the younger group adjusted for sex, BMI, smoking, and subject groups was 1.60 (95% CI, 1.00-2.55), while the corresponding OR of the older group was 1.27 (95% CI, 0.85-1.90).
###end p 24
###begin title 25
4. Discussion
###end title 25
###begin p 26
###xml 46 56 46 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori </italic>
###xml 469 479 467 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori </italic>
###xml 46 55 <span type="species:ncbi:210">H. pylori</span>
###xml 469 478 <span type="species:ncbi:210">H. pylori</span>
The present paper examined the association of H. pylori seropositivity with hsCRP in the range of 0.002 to 1.0 mg/dl, based on three different Japanese groups with 1,157 subjects in total. Although the background of the three groups was different, the sex, age, BMI, and smoking adjusted OR of the seropositive for hsCRP > 0.1 mg/dl relative to hsCRP <== 0.1 mg/dl was larger than unity in all three groups. The summary OR was 1.38 (95% CI, 1.01-1.89), indicating that H. pylori seropositivity was associated with a higher hsCRP among those with hsCRP <== 1 mg/dl. We tested the heterogeneity of the OR for high CRP levels in relation to the seropositivity among three groups. Because no significant differences in the OR were found among study groups, we pooled the data derived from three different populations.
###end p 26
###begin p 27
###xml 9 19 9 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori </italic>
###xml 205 215 205 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori </italic>
###xml 260 270 260 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori </italic>
###xml 369 379 369 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori </italic>
###xml 517 519 517 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 573 583 573 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori </italic>
###xml 583 585 583 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 605 615 605 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori </italic>
###xml 919 929 919 929 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori </italic>
###xml 1035 1037 1035 1037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 1138 1148 1138 1148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori </italic>
###xml 9 18 <span type="species:ncbi:210">H. pylori</span>
###xml 205 214 <span type="species:ncbi:210">H. pylori</span>
###xml 260 269 <span type="species:ncbi:210">H. pylori</span>
###xml 369 378 <span type="species:ncbi:210">H. pylori</span>
###xml 573 582 <span type="species:ncbi:210">H. pylori</span>
###xml 605 614 <span type="species:ncbi:210">H. pylori</span>
###xml 919 928 <span type="species:ncbi:210">H. pylori</span>
###xml 1138 1147 <span type="species:ncbi:210">H. pylori</span>
Although H. pylori infection is associated with coronary artery disease, the pathway to elevate the disease risk is not clear. There are several possibilities for the mechanism underlying a causal role of H. pylori infection in endothelial dysfunction. First, H. pylori may have the direct effect on the structure and function of vascular endothelial cells. Extract of H. pylori has been reported to induce a disturbance of proliferation and apoptosis and to decrease viability of cultured vascular endothelial cells 25. The second possibility is the nutritional effect of H. pylori 26. An infection from H. pylori may cause malabsorption of folate, vitamin B6, and vitamin B12. This nutritional defect could lead to failure of methylation by 5-methyl-tetrahydrofolic acid and subsequent hyperhomocysteinanemia, which is toxic to endothelial cells. In our past study, serum folate was examined as a molecule connecting H. pylori infection with systemic diseases, resulting in no association between the seropositivity and serum folate 27. CRP is also one of the candidate molecules, but there were limited reports on the association with H. pylori infection.
###end p 27
###begin p 28
###xml 26 36 26 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori </italic>
###xml 238 240 238 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 327 337 327 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori </italic>
###xml 436 438 436 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 476 486 476 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori </italic>
###xml 26 35 <span type="species:ncbi:210">H. pylori</span>
###xml 57 65 <span type="species:ncbi:9606">patients</span>
###xml 69 75 <span type="species:ncbi:9103">Turkey</span>
###xml 135 147 <span type="species:ncbi:9606">participants</span>
###xml 194 206 <span type="species:ncbi:9606">participants</span>
###xml 327 336 <span type="species:ncbi:210">H. pylori</span>
###xml 341 361 <span type="species:ncbi:83558">Chlamydia pneumoniae</span>
###xml 476 485 <span type="species:ncbi:210">H. pylori</span>
A study on the effects of H. pylori eradication among 78 patients in Turkey reported that serum CRP was significantly reduced among 57 participants with successful eradication, but not among 21 participants in whom the eradication failed 23. Another study reported that increasing age, smoking, symptoms of chronic bronchitis, H. pylori and Chlamydia pneumoniae infections, and BMI were all associated with raised concentrations of CRP 24. The present study demonstrated that H. pylori infection may slightly elevate serum CRP, thereby may increase systemic disease risk.
###end p 28
###begin p 29
###xml 625 627 625 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 438 444 <span type="species:ncbi:13443">coffee</span>
CRP is an easily measurable substance in blood. Increased levels of this protein indicate acute inflammation. Many studies have shown that high levels of CRP also indicate an increased risk of suffering from a heart attack or stroke. The CRP test is not specific, and the levels fluctuate daily and throughout the day. The levels increase as a result of numerous factors including aging, alcohol use, smoking, eating a high protein diet, coffee consumption, low levels of physical activity, chronic fatigue, high blood pressure, BMI, high triglycerides, rheumatoid arthritis, rheumatic fever, insulin resistance and diabetes 28, as well as heart attack. Medicines containing estrogen (oral contraceptive and hormone replacement therapy) may also elevate CRP levels. In this study, we took factors, sex, age, BMI, and smoking into account, although information on BMI and smoking was not available for PIC group. Among the female subjects, smokers and fatty ladies were relatively rare.
###end p 29
###begin p 30
###xml 50 60 50 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori </italic>
###xml 368 378 368 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori </italic>
###xml 524 533 524 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori</italic>
###xml 570 579 570 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori</italic>
###xml 621 632 621 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> H. pylori </italic>
###xml 817 826 817 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori</italic>
###xml 1076 1078 1076 1078 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 1080 1082 1080 1082 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 50 59 <span type="species:ncbi:210">H. pylori</span>
###xml 368 377 <span type="species:ncbi:210">H. pylori</span>
###xml 524 533 <span type="species:ncbi:210">H. pylori</span>
###xml 570 579 <span type="species:ncbi:210">H. pylori</span>
###xml 622 631 <span type="species:ncbi:210">H. pylori</span>
###xml 817 826 <span type="species:ncbi:210">H. pylori</span>
The present study has several limitations. First, H. pylori infection was determined by only serum antibody, not by the other diagnosis methods with a higher sensitivity and specificity, such as a urease breath test. Since the present analysis was based on stored blood samples from multi-purpose studies, alternative methods could not be applied for the detection of H. pylori infection. Second, the information on the other factors that affect serum CRP level was not available. For example, chronic infections other than H. pylori could confound the association with H. pylori infection, since it seemed plausible that H. pylori infected individuals might be vulnerable to other infections which elevate CRP. The adjustments of the potential confounding factors might not be enough to confirm the association with H. pylori infection. Third, this study was a cross-sectional study so that the causal inference was not possible directly. Finally, the effects of medication on CRP were not removed. Since several drugs, such as statins, were reported to influence CRP levels 29, 30, the adjustment for such medications could allow clear interpretation on the observed association.
###end p 30
###begin p 31
###xml 3 13 3 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori </italic>
###xml 129 139 129 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori </italic>
###xml 271 273 271 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 275 277 275 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 279 289 279 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori </italic>
###xml 370 372 370 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 374 376 374 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 468 478 468 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori </italic>
###xml 503 505 503 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 581 583 581 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 585 587 585 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 654 656 654 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 710 712 710 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 931 941 927 937 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori </italic>
###xml 3 12 <span type="species:ncbi:210">H. pylori</span>
###xml 129 138 <span type="species:ncbi:210">H. pylori</span>
###xml 279 288 <span type="species:ncbi:210">H. pylori</span>
###xml 341 346 <span type="species:ncbi:9606">human</span>
###xml 468 477 <span type="species:ncbi:210">H. pylori</span>
###xml 931 940 <span type="species:ncbi:210">H. pylori</span>
If H. pylori has effects on the function of vascular endothelial cells, serum CRP could be one of the molecules to connect both. H. pylori infection stimulates the production of proinflammatory cytokines such as tumor necrosis factor (TNF), interleukin (IL) -6, and IL-8 31, 32. H. pylori was detected not only in gastric mucosa but also in human atherosclerotic plaque 33, 34, and the expression of intercellular adhension molecule-1 was higher in plaques containing H. pylori than in those without it 33. The production of CRP is regulated by cytokines, principally interleukins 35, 36, whose effects are modified by other cytokines and growth factors 37, as well as by hormones such as cortisol and insulin 38. Production of cytokines and stress hormones may be altered in conditions other than inflammation or injury. TNF-alpha is a potent inducer of IL-6 by various cells. Therefore, the association of CRP concentration with H. pylori infection could be explained by the actions of cytokines, hormones, or both.
###end p 31
###begin p 32
###xml 128 138 128 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori </italic>
###xml 188 197 188 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori</italic>
###xml 264 274 264 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori </italic>
###xml 321 331 321 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori </italic>
###xml 128 137 <span type="species:ncbi:210">H. pylori</span>
###xml 188 197 <span type="species:ncbi:210">H. pylori</span>
###xml 264 273 <span type="species:ncbi:210">H. pylori</span>
###xml 321 330 <span type="species:ncbi:210">H. pylori</span>
In conclusion, the present cross-sectional study based on the three different subjects showed a significant association between H. pylori infection and serum hsCRP levels, supporting that H. pylori infection may increase the serum CRP. The possible attribution of H. pylori infection to CRP elevation could be a route to H. pylori negative subjects related coronary heart disease with the base of atherosclerosis. Since many factors influence the CRP levels, larger studies with information on potential confounding factors are necessary to confirm the association.
###end p 32
###begin p 33
The authors are grateful to Ms. Yoko Mitsuda for their technical assistance. This work was supported in part by a Grant-in-Aid for Scientific Research on Special Priority Areas of Cancer from the Ministry of Education, Culture, Sports, Science and Technology of Japan.
###end p 33
###begin article-title 34
###xml 38 57 38 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Helicobacter pylori</italic>
###xml 38 57 <span type="species:ncbi:210">Helicobacter pylori</span>
Epidemiology of, and risk factor for, Helicobacter pylori infection among 3194 asymptomatic subjects in 17 populations
###end article-title 34
###begin article-title 35
###xml 24 43 24 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Helicobacter pylori</italic>
###xml 24 43 <span type="species:ncbi:210">Helicobacter pylori</span>
Clinical expressions of Helicobacter pylori infection
###end article-title 35
###begin article-title 36
###xml 0 19 0 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Helicobacter pylori</italic>
###xml 0 19 <span type="species:ncbi:210">Helicobacter pylori</span>
Helicobacter pylori infection and respiratory diseases: a review
###end article-title 36
###begin article-title 37
###xml 15 25 15 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori </italic>
###xml 15 24 <span type="species:ncbi:210">H. pylori</span>
Association of H. pylori infection with elevated serum lipids
###end article-title 37
###begin article-title 38
###xml 14 24 14 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori </italic>
###xml 14 23 <span type="species:ncbi:210">H. pylori</span>
###xml 84 92 <span type="species:ncbi:9606">patients</span>
Prevalence of H. pylori infection and its link to coronary risk factors in Japanese patients with acute myocardial infarction
###end article-title 38
###begin article-title 39
###xml 6 16 6 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori </italic>
###xml 6 15 <span type="species:ncbi:210">H. pylori</span>
Could H. pylori infection increase the risk of coronary heart disease by modifying serum lipid concentrations?
###end article-title 39
###begin article-title 40
###xml 0 19 0 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Helicobacter pylori</italic>
###xml 0 19 <span type="species:ncbi:210">Helicobacter pylori</span>
Helicobacter pylori is an aetiologic factor for ischaemic heart disease: the case against
###end article-title 40
###begin article-title 41
###xml 33 42 33 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori</italic>
###xml 33 42 <span type="species:ncbi:210">H. pylori</span>
Extradigestive manifestations of H. pylori infection. Fact and fiction
###end article-title 41
###begin article-title 42
###xml 28 38 28 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori </italic>
###xml 28 37 <span type="species:ncbi:210">H. pylori</span>
Extradigestive diseases and H. pylori infection
###end article-title 42
###begin article-title 43
###xml 25 30 <span type="species:ncbi:9606">human</span>
The complete sequence of human preprocalcitonin
###end article-title 43
###begin article-title 44
###xml 84 87 <span type="species:ncbi:9606">men</span>
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
###end article-title 44
###begin article-title 45
###xml 100 105 <span type="species:ncbi:9606">women</span>
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
###end article-title 45
###begin article-title 46
Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events
###end article-title 46
###begin article-title 47
C-reactive protein, the metabolic syndrome and risk of incident cardiovascular events
###end article-title 47
###begin article-title 48
Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: results from the Cardiovascular Health Study and the Rural Health Promotion Project
###end article-title 48
###begin article-title 49
Low grade inflammation and coronary heart disease: prospective study and updated meta-analysis
###end article-title 49
###begin article-title 50
###xml 135 138 <span type="species:ncbi:9606">men</span>
C-reactive protein, a sensitive marker of inflammation predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (monitoring trends and determinants in cardiovascular disease) Augsburg Cohort Study, 1984 to 1992
###end article-title 50
###begin article-title 51
Relation of C-reactive protein and coronary artery heart disease in the MRFIT nested casecontrol study: multiple risk factor intervention trial
###end article-title 51
###begin article-title 52
Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death
###end article-title 52
###begin article-title 53
C-reactive protein: a critical update
###end article-title 53
###begin article-title 54
Evidence of smoke and atherosclerotic fire
###end article-title 54
###begin article-title 55
###xml 12 31 12 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Helicobacter pylori</italic>
###xml 12 31 <span type="species:ncbi:210">Helicobacter pylori</span>
Relation of Helicobacter pylori infection and coronary heart disease
###end article-title 55
###begin article-title 56
###xml 94 114 94 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Helicobacter pylori </italic>
###xml 94 113 <span type="species:ncbi:210">Helicobacter pylori</span>
Do procalcitonin and C-reactive protein levels have a place in the diagnosis and follow-up of Helicobacter pylori infections?
###end article-title 56
###begin article-title 57
C Reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study
###end article-title 57
###begin article-title 58
###xml 46 65 46 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Helicobacter pylori</italic>
###xml 46 65 <span type="species:ncbi:210">Helicobacter pylori</span>
###xml 69 74 <span type="species:ncbi:9606">human</span>
Effects of genotypically different strains of Helicobacter pylori on human microvascular endothelial cells in vitro
###end article-title 58
###begin article-title 59
###xml 24 43 24 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Helicobacter pylori</italic>
###xml 24 43 <span type="species:ncbi:210">Helicobacter pylori</span>
Hyperhomocysteinanemia, Helicobacter pylori, and coronary heart disease
###end article-title 59
###begin article-title 60
Associations of methylenetetrahydrofolate reductase (MTHFR) polymorphism with hyperuricemia in Japanese
###end article-title 60
###begin article-title 61
Impact of C-reactive protein on disease risk and its relation to dietary factors: literature review
###end article-title 61
###begin article-title 62
Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) Investigators: C-reactive protein levels and outcomes after statin therapy
###end article-title 62
###begin article-title 63
Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE). a randomized trial and cohort study
###end article-title 63
###begin article-title 64
###xml 72 92 72 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Helicobacter pylori </italic>
###xml 58 66 <span type="species:ncbi:9606">patients</span>
###xml 72 91 <span type="species:ncbi:210">Helicobacter pylori</span>
Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis
###end article-title 64
###begin article-title 65
###xml 28 47 28 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Helicobacter pylori</italic>
###xml 28 47 <span type="species:ncbi:210">Helicobacter pylori</span>
Cytokine gene expression in Helicobacter pylori associated antral gastritis
###end article-title 65
###begin article-title 66
###xml 38 57 38 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Helicobacter pylori</italic>
###xml 13 33 <span type="species:ncbi:83558">Chlamydia pneumoniae</span>
###xml 38 57 <span type="species:ncbi:210">Helicobacter pylori</span>
###xml 65 70 <span type="species:ncbi:9606">human</span>
Detection of Chlamydia pneumoniae and Helicobacter pylori DNA in human atherosclerotic plaques by PCR
###end article-title 66
###begin article-title 67
###xml 13 32 13 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Helicobacter pylori</italic>
###xml 13 32 <span type="species:ncbi:210">Helicobacter pylori</span>
###xml 36 41 <span type="species:ncbi:9606">human</span>
Detection of Helicobacter pylori in human carotid atherosclerotic plaques
###end article-title 67
###begin article-title 68
Effects of the acute phase response on the concentration and density distribution of plasma lipids and apolipoproteins
###end article-title 68
###begin article-title 69
IFNB2/BSF2/IL-6 is the monocyte-derived HSF that regulates receptor-specific acute phase gene regulation in hepatocytes
###end article-title 69
###begin article-title 70
###xml 74 79 <span type="species:ncbi:9606">human</span>
Effects of cytokine combinations on acute phase protein production in two human hepatoma cell lines
###end article-title 70
###begin article-title 71
The acute phase response
###end article-title 71
###begin p 72
Characteristics of subjects from three study groups
###end p 72
###begin p 73
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 35 41 35 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8224;</sup>
###xml 87 100 82 83 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8225;</sup>
###xml 102 110 <span type="species:ncbi:9606">Patients</span>
YTI*: Yakumo Town Inhabitants, ENUHdagger: Examinees of Nagoya University Hospital, PICdouble dagger: Patients of Infertility Clinic, Nagoya University Hospital.
###end p 73
###begin p 74
Percentages are shown in parentheses.
###end p 74
###begin p 75
Associations between the serum level of hsCRP and background factors
###end p 75
###begin p 76
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 35 41 35 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8224;</sup>
###xml 87 100 82 83 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8225;</sup>
###xml 163 175 146 147 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#167;</sup>
###xml 199 201 169 170 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8214;</sup>
###xml 230 244 199 200 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#182;</sup>
###xml 102 109 <span type="species:ncbi:9606">Patient</span>
YTI*: Yakumo Town Inhabitants, ENUHdagger: Examinees of Nagoya University Hospital, PICdouble dagger: Patient of Infertility Clinic, Nagoya Unversity Hospital, Lowsection sign: hsCRP<==0.1mg/dl, High||: hsCRP>0.1mg/dl, and p-valueparagraph sign: Fisher's exact test.
###end p 76
###begin p 77
Percentages are shown in parentheses.
###end p 77
###begin p 78
###xml 46 55 46 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori</italic>
###xml 127 136 127 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori</italic>
###xml 46 55 <span type="species:ncbi:210">H. pylori</span>
###xml 127 136 <span type="species:ncbi:210">H. pylori</span>
Associations of the serum level of hsCRP with H. pylori seropositivity and odds ratio (OR) and 95% confidence interval (CI) of H. pylori for hsCRP
###end p 78
###begin p 79
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 28 34 26 27 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8224;</sup>
###xml 52 65 45 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8225;</sup>
###xml 104 117 85 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8225;</sup>
###xml 120 132 89 90 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#167;</sup>
###xml 185 197 143 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#167;</sup>
###xml 203 205 150 151 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8214;</sup>
###xml 236 250 182 183 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#182;</sup>
###xml 296 298 229 231 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">**</sup>
###xml 366 378 299 301 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8224;&#8224;</sup>
###xml 300 308 <span type="species:ncbi:9606">Patients</span>
Low*: hsCRP<==0.1mg/dl, Highdagger: hsCRP>0.1mg/dl, double daggerSex-, and age-adjusted odds ratios (aORdouble dagger), section signSex-, age- smoking- and BMI-adjusted odds ratios (aORsection sign), YTI||: Yakumo Town Inhabitants, ENUHparagraph sign: Examinees of Nagoya University Hospital, PIC**: Patients of Infertility Clinic, Nagoya University Hospital, Pooleddaggerdagger: three studies were combined, and the ORs were adjusted additionally for the study groups using dummy variables.
###end p 79
###begin p 80
Percentages are shown in parentheses.
###end p 80

